List of Tables
Table 1. Global Osimertinib Generics Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Osimertinib Generics Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Osimertinib Generics Market Competitive Situation by Manufacturers in 2025
Table 4. Global Osimertinib Generics Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Osimertinib Generics Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Osimertinib Generics Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Osimertinib Generics Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Osimertinib Generics Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Osimertinib Generics, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Osimertinib Generics, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Osimertinib Generics, Product Types and Applications
Table 12. Global Key Manufacturers of Osimertinib Generics, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osimertinib Generics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Osimertinib Generics Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osimertinib Generics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Osimertinib Generics Sales by Region (K Units), 2021–2026
Table 18. Global Osimertinib Generics Sales Market Share by Region (2021–2026)
Table 19. Global Osimertinib Generics Sales by Region (K Units), 2027–2032
Table 20. Global Osimertinib Generics Sales Market Share by Region (2027–2032)
Table 21. Global Osimertinib Generics Revenue by Region (US$ Million), 2021–2026
Table 22. Global Osimertinib Generics Revenue Market Share by Region (2021–2026)
Table 23. Global Osimertinib Generics Revenue by Region (US$ Million), 2027–2032
Table 24. Global Osimertinib Generics Revenue Market Share by Region (2027–2032)
Table 25. North America Osimertinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Osimertinib Generics Sales by Country (K Units), 2021–2026
Table 27. North America Osimertinib Generics Sales by Country (K Units), 2027–2032
Table 28. North America Osimertinib Generics Revenue by Country (US$ Million), 2021–2026
Table 29. North America Osimertinib Generics Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Osimertinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Osimertinib Generics Sales by Country (K Units), 2021–2026
Table 32. Europe Osimertinib Generics Sales by Country (K Units), 2027–2032
Table 33. Europe Osimertinib Generics Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Osimertinib Generics Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Osimertinib Generics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Osimertinib Generics Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Osimertinib Generics Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Osimertinib Generics Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Osimertinib Generics Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Osimertinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Osimertinib Generics Sales by Country (K Units), 2021–2026
Table 42. Latin America Osimertinib Generics Sales by Country (K Units), 2027–2032
Table 43. Latin America Osimertinib Generics Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Osimertinib Generics Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Osimertinib Generics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Osimertinib Generics Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Osimertinib Generics Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Osimertinib Generics Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Osimertinib Generics Revenue by Country (US$ Million), 2027–2032
Table 50. Global Osimertinib Generics Sales (K Units) by Type (2021–2026)
Table 51. Global Osimertinib Generics Sales (K Units) by Type (2027–2032)
Table 52. Global Osimertinib Generics Sales Market Share by Type (2021–2026)
Table 53. Global Osimertinib Generics Sales Market Share by Type (2027–2032)
Table 54. Global Osimertinib Generics Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Osimertinib Generics Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Osimertinib Generics Revenue Market Share by Type (2021–2026)
Table 57. Global Osimertinib Generics Revenue Market Share by Type (2027–2032)
Table 58. Global Osimertinib Generics Price (US$/Unit) by Type (2021–2026)
Table 59. Global Osimertinib Generics Price (US$/Unit) by Type (2027–2032)
Table 60. Global Osimertinib Generics Sales (K Units) by Application (2021–2026)
Table 61. Global Osimertinib Generics Sales (K Units) by Application (2027–2032)
Table 62. Global Osimertinib Generics Sales Market Share by Application (2021–2026)
Table 63. Global Osimertinib Generics Sales Market Share by Application (2027–2032)
Table 64. Global Osimertinib Generics Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Osimertinib Generics Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Osimertinib Generics Revenue Market Share by Application (2021–2026)
Table 67. Global Osimertinib Generics Revenue Market Share by Application (2027–2032)
Table 68. Global Osimertinib Generics Price (US$/Unit) by Application (2021–2026)
Table 69. Global Osimertinib Generics Price (US$/Unit) by Application (2027–2032)
Table 70. Zydus Company Information
Table 71. Zydus Description and Business Overview
Table 72. Zydus Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zydus Osimertinib Generics Product
Table 74. Zydus Recent Developments/Updates
Table 75. Wanbang Biopharmaceuticals Company Information
Table 76. Wanbang Biopharmaceuticals Description and Business Overview
Table 77. Wanbang Biopharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Wanbang Biopharmaceuticals Osimertinib Generics Product
Table 79. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 80. Drug International Company Information
Table 81. Drug International Description and Business Overview
Table 82. Drug International Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Drug International Osimertinib Generics Product
Table 84. Drug International Recent Developments/Updates
Table 85. Beacon Company Information
Table 86. Beacon Description and Business Overview
Table 87. Beacon Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Beacon Osimertinib Generics Product
Table 89. Beacon Recent Developments/Updates
Table 90. General Pharmaceuticals Company Information
Table 91. General Pharmaceuticals Description and Business Overview
Table 92. General Pharmaceuticals Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. General Pharmaceuticals Osimertinib Generics Product
Table 94. General Pharmaceuticals Recent Developments/Updates
Table 95. Pharmacil Company Information
Table 96. Pharmacil Description and Business Overview
Table 97. Pharmacil Osimertinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Pharmacil Osimertinib Generics Product
Table 99. Pharmacil Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Osimertinib Generics Distributors List
Table 103. Osimertinib Generics Customers List
Table 104. Osimertinib Generics Market Trends
Table 105. Osimertinib Generics Market Drivers
Table 106. Osimertinib Generics Market Challenges
Table 107. Osimertinib Generics Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Osimertinib Generics
Figure 2. Global Osimertinib Generics Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Osimertinib Generics Market Share by Type: 2025 & 2032
Figure 4. 40mg per Tablet Product Picture
Figure 5. 80mg per Tablet Product Picture
Figure 6. Global Osimertinib Generics Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Osimertinib Generics Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Osimertinib Generics Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Osimertinib Generics Market Size (US$ Million), 2021–2032
Figure 13. Global Osimertinib Generics Sales (K Units), 2021–2032
Figure 14. Global Osimertinib Generics Average Price (US$/Unit), 2021–2032
Figure 15. Osimertinib Generics Report Years Considered
Figure 16. Osimertinib Generics Sales Share by Manufacturers in 2025
Figure 17. Global Osimertinib Generics Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Osimertinib Generics Players: Market Share by Revenue in Osimertinib Generics in 2025
Figure 19. Osimertinib Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Osimertinib Generics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Osimertinib Generics Sales Market Share by Country (2021–2032)
Figure 22. North America Osimertinib Generics Revenue Market Share by Country (2021–2032)
Figure 23. United States Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Osimertinib Generics Sales Market Share by Country (2021–2032)
Figure 26. Europe Osimertinib Generics Revenue Market Share by Country (2021–2032)
Figure 27. Germany Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Osimertinib Generics Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Osimertinib Generics Revenue Market Share by Region (2021–2032)
Figure 34. China Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Osimertinib Generics Sales Market Share by Country (2021–2032)
Figure 42. Latin America Osimertinib Generics Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Osimertinib Generics Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Osimertinib Generics Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Osimertinib Generics Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Osimertinib Generics by Type (2021–2032)
Figure 53. Global Revenue Market Share of Osimertinib Generics by Type (2021–2032)
Figure 54. Global Osimertinib Generics Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Osimertinib Generics by Application (2021–2032)
Figure 56. Global Revenue Market Share of Osimertinib Generics by Application (2021–2032)
Figure 57. Global Osimertinib Generics Price (US$/Unit) by Application (2021–2032)
Figure 58. Osimertinib Generics Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
